JP2025508098A5 - - Google Patents
Info
- Publication number
- JP2025508098A5 JP2025508098A5 JP2024553621A JP2024553621A JP2025508098A5 JP 2025508098 A5 JP2025508098 A5 JP 2025508098A5 JP 2024553621 A JP2024553621 A JP 2024553621A JP 2024553621 A JP2024553621 A JP 2024553621A JP 2025508098 A5 JP2025508098 A5 JP 2025508098A5
- Authority
- JP
- Japan
- Prior art keywords
- nintedanib
- use according
- tuberculosis
- drugs
- ethanesulfonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210463752.6 | 2022-04-29 | ||
| CN202210463752.6A CN114732818B (zh) | 2022-04-29 | 2022-04-29 | 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用 |
| PCT/CN2023/081772 WO2023207398A1 (zh) | 2022-04-29 | 2023-03-16 | 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508098A JP2025508098A (ja) | 2025-03-21 |
| JP2025508098A5 true JP2025508098A5 (cg-RX-API-DMAC7.html) | 2025-06-16 |
| JP7844766B2 JP7844766B2 (ja) | 2026-04-14 |
Family
ID=82285173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553621A Active JP7844766B2 (ja) | 2022-04-29 | 2023-03-16 | 抗特発性肺線維症薬ニンテダニブの結核を治療するための使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250099458A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7844766B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114732818B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023207398A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202405173B (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114732818B (zh) * | 2022-04-29 | 2023-02-10 | 首都医科大学附属北京胸科医院 | 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用 |
| CN115645405B (zh) * | 2022-11-10 | 2023-11-21 | 南方医科大学 | 顺苯磺酸阿曲库铵在制备抗结核抗生素增效剂中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1857725A (zh) * | 2006-04-11 | 2006-11-08 | 济南帅华医药科技有限公司 | 一种含增效剂的复方抗结核药物缓释制剂 |
| EP2311457A1 (en) * | 2009-10-19 | 2011-04-20 | Forschungszentrum Borstel | Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
| WO2015107482A1 (en) * | 2014-01-17 | 2015-07-23 | Piramal Enterprises Limited | Pharmaceutical combination for treatment of tuberculosis |
| DK3377064T3 (da) * | 2016-01-08 | 2019-09-23 | Nerre Therapeutics Ltd | Orvepitant til behandling af kronisk hoste |
| CN107019697A (zh) * | 2016-02-02 | 2017-08-08 | 瑞阳(苏州)生物科技有限公司 | 预防或治疗纤维化疾病的药物组合物及其应用 |
| GB201607865D0 (en) * | 2016-05-05 | 2016-06-22 | Ucl Business Plc | Anti-tuberculous polymersomes |
| CN105902507A (zh) * | 2016-06-12 | 2016-08-31 | 佛山市腾瑞医药科技有限公司 | 一种乙磺酸尼达尼布制剂及其应用 |
| CN114732818B (zh) * | 2022-04-29 | 2023-02-10 | 首都医科大学附属北京胸科医院 | 一种抗特发性肺纤维化药物尼达尼布在结核病治疗中的应用 |
-
2022
- 2022-04-29 CN CN202210463752.6A patent/CN114732818B/zh active Active
-
2023
- 2023-03-16 JP JP2024553621A patent/JP7844766B2/ja active Active
- 2023-03-16 US US18/727,731 patent/US20250099458A1/en active Pending
- 2023-03-16 WO PCT/CN2023/081772 patent/WO2023207398A1/zh not_active Ceased
-
2024
- 2024-07-02 ZA ZA2024/05173A patent/ZA202405173B/en unknown